Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Gsk (GLAXF) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Gsk (GLAXF) over the last 17 years, with Q4 2025 value amounting to -$601.2 million.

  • Gsk's Change in Intangibles fell 294.22% to -$601.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$2.2 billion, marking a year-over-year decrease of 1693.41%. This contributed to the annual value of -$2.2 billion for FY2025, which is 668.41% down from last year.
  • According to the latest figures from Q4 2025, Gsk's Change in Intangibles is -$601.2 million, which was down 294.22% from -$766.3 million recorded in Q3 2025.
  • In the past 5 years, Gsk's Change in Intangibles ranged from a high of -$176.7 million in Q2 2024 and a low of -$2.3 billion during Q4 2021
  • In the last 5 years, Gsk's Change in Intangibles had a median value of -$504.4 million in 2022 and averaged -$590.6 million.
  • In the last 5 years, Gsk's Change in Intangibles tumbled by 20157.14% in 2021 and then skyrocketed by 8256.18% in 2022.
  • Gsk's Change in Intangibles (Quarter) stood at -$2.3 billion in 2021, then skyrocketed by 69.52% to -$700.2 million in 2022, then rose by 5.17% to -$664.0 million in 2023, then rose by 12.05% to -$584.0 million in 2024, then fell by 2.94% to -$601.2 million in 2025.
  • Its Change in Intangibles was -$601.2 million in Q4 2025, compared to -$766.3 million in Q3 2025 and -$502.9 million in Q2 2025.